India's Sun Pharma rises as quarterly profit before exceptional items and tax increases
BUZZ-India's Sun Pharma rises as quarterly profit before exceptional items and tax increases ** Shares of Sun Pharmaceuticals SUN.NS rise as much as 5.3% to 1,855 rupees; last up 2.8%
** Drugmaker posts 6.3% increase in Q2 profit before exceptional items and tax
** Net profit fell 36%, due to one-time charge largely linked to co's planned acquisition of Organon; rev from ops rose 12%
** More than 3.7 million shares traded by 2:57 pm, 2.4x the 30-day avg
** Stock on avg rated "buy" by 31 analysts; median PT is 2,180 rupees - LSEG-compiled data
** Stock up 5.4% YTD
(Reporting by Abhirami G in Bengaluru)
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses